Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 26, 2026

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
06:45

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System

Published on: July 2, 2020

Tailored magnetic nanoparticles for optimizing magnetic fluid hyperthermia.

Amit P Khandhar1, R Matthew Ferguson, Julian A Simon

  • 1Department of Materials Science & Engineering, University of Washington, Materials Science and Engineering, Seattle, Washington 98195, USA.

Journal of Biomedical Materials Research. Part A
|January 4, 2012
PubMed
Summary

Optimizing magnetic fluid hyperthermia (MFH) involves tailoring iron oxide magnetic nanoparticle (MNP) size to specific alternating magnetic field (AMF) frequencies. This study demonstrates how precise MNP synthesis enhances cancer therapy efficiency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An RNA-to-RNA pipeline for rapid antiviral antibody development.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Antigen-dependent interplay of formulation, systemic innate responses, and antibody responses to multi-component replicon RNA vaccination.

Molecular therapy. Nucleic acids·2025
Same author

Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from disease.

Nature communications·2025
Same author

Highly immunogenic DNA/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques.

iScience·2025
Same author

Multiple mechanisms of aminoglycoside ototoxicity are distinguished by subcellular localization of action.

Frontiers in neurology·2024
Same author

Preclinical development of lyophilized self-replicating RNA vaccines for COVID-19 and malaria with improved long-term thermostability.

Journal of controlled release : official journal of the Controlled Release Society·2024

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Magnetic Fluid Hyperthermia (MFH) utilizes magnetic nanoparticles (MNPs) for localized tumor heating via alternating magnetic fields (AMF).
  • Optimizing MFH requires precise control over MNP properties, including size and size distribution, to maximize heating efficiency.

Purpose of the Study:

  • To optimize Magnetic Fluid Hyperthermia (MFH) by tailoring iron oxide magnetic nanoparticle (MNP) size to specific alternating magnetic field (AMF) frequencies.
  • To develop a synthesis and characterization protocol for producing water-stable MNPs suitable for MFH applications.

Main Methods:

  • Organic synthesis routes were employed for precise control over MNP size (10-25 nm), size distribution, and phase purity.
  • Biocompatible amphiphilic polymers were used for aqueous phase transfer, ensuring colloidal and long-term shelf stability.

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

Related Experiment Videos

Last Updated: May 26, 2026

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
06:45

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System

Published on: July 2, 2020

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

  • Rigorous characterization confirmed MNP uniformity, phase purity, stable magnetic properties, colloidal stability, shelf life, and low in vitro toxicity.

    • Main Results:

    • Monodisperse 16 nm MNPs showed optimal response to AMF conditions (373 kHz, 14 kA/m), achieving maximum Specific Loss Power (SLP).
    • Broader size distribution in MNPs led to a 30% decrease in SLP.
    • Tailored MNPs demonstrated maximum hyperthermia efficiency, significantly reducing Jurkat cell viability in vitro.

    Conclusions:

    • Intrinsic optimization of MFH is achievable by precisely tailoring MNP characteristics to the applied AMF.
    • This approach is a crucial precursor for optimizing MFH treatment dosage and duration.
    • The developed method offers a pathway for enhanced efficacy in cancer therapy using magnetic fluid hyperthermia.